ecancermedicalscience

Submit article

https://doi.org/10.3332/ecancer.2015.525

Abstract | Full Article |

Research

Curcumin modulates cellular AP-1, NF-kB, and HPV16 E6 proteins in oral cancer

22 Apr 2015

Alok Mishra, Rakesh Kumar, Abhishek Tyagi, Indu Kohaar, Suresh Hedau, Alok C Bharti, Subhodeep Sarker, Dipankar Dey, Daman Saluja, Bhudev Das

In this study, we investigated the effects of the natural antioxidant curcumin on the HPV16-positive oral carcinoma cell line 93VU147T and demonstrated that curcumin is not only a potent inhibitor for the activity of host nuclear transcription factors AP-1 and NF-kB but it also selectively suppresses transcription of the HPV16/E6 oncogene during the carcinogenic process in oral cancer cells. This study suggests a therapeutic potential of curcumin for high-risk human papilloma virus (HPV)-infected oral cancers.

Article metrics: 7629 views

3661

3968

2150-safety-of-immune-checkpoint-inhibitors-in-a-diverse-patient-population-a-single-institution-experience

Short Communication: Safety of immune checkpoint inhibitors in a diverse patient population: a single-institution experience

Grace M Ferri*, John F Murphy*, Akash Oza*, Alexander J B Bulteel, Wafaa Abbasi, Rachel Anderson, Mehmed Taha Dinc, Eva Gaufberg, Kayra Cengiz, Sainikhil Sontha, Janice Weinberg, Patrick Kurpaska, Yashvin Onkarappa Mangala, Matthew Kulke, Umit Tapan

18 Jun 2026

https://doi.org/10.3332/ecancer.2026.2150

Abstract | Full Article | PDF

2149-bringing-leaders-together-to-support-the-development-of-childrens-palliative-care-across-the-asia-pacific-region-an-interdisciplinary-workshop

Conference Report: Bringing leaders together to support the development of children’s palliative care across the Asia Pacific region—an interdisciplinary workshop

Gemma E Aburn, Rima Saad Rassam, Ximena Garcia-Quintero, Marta Salek, Andrea Cuviello, Yadurshini Raveendran, Sri Andini Handayani, Chen Chen Sun, Su Yadana, Sally Blair, Megan Doherty, Min Sun Kim, Zhou Xuan, Marianne B Phillips, Lee Ai Chong, Gayatri Palat, Donna Drew, Justin N Baker, Poh Heng Chong, Julia Downing, Michael J McNei

17 Jun 2026

https://doi.org/10.3332/ecancer.2026.2149

Abstract | Full Article | PDF

2147-benchmarking-of-radiobiological-ntcp-models-in-head-and-neck-radiotherapy-using-independent-computational-pipelines-an-institutional-validation-study-with-machine-learning-augmentation

Research: Benchmarking of radiobiological NTCP models in head and neck radiotherapy using independent computational pipelines: an institutional validation study with machine learning augmentation

Kalyan Mondal, Abhijit Mandal, Anuj Vijay1c, Ganeshkumar Patel

16 Jun 2026

https://doi.org/10.3332/ecancer.2026.2147

Abstract | Full Article | PDF

2144-use-of-low-dose-immune-checkpoint-inhibitors-in-low-and-middle-income-countries-a-national-survey-of-oncologists-and-hematologists-in-mexico

Research: Use of low-dose immune checkpoint inhibitors in low- and middle-income countries: a national survey of oncologists and hematologists in Mexico

Andres Meraz-Brenez, Enrique Soto-Perez-De-Celis, Roberta Demichelis-Gomez, Leonardo Verduzco-Rodriguez, Arjun Gupta, Meera Ragavan, Fumiko Chino, Haydee Cristina Verduzco-Aguirre

10 Jun 2026

https://doi.org/10.3332/ecancer.2026.2144

Abstract | Full Article | PDF